DOCSLIB.ORG

Typology and Profile of Spine Muscles. Structure of Myofibrils and Role of Protein Components – Review of Current Literature

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Ovidius University Annals, Series Physical Education and Sport / SCIENCE, MOVEMENT AND HEALTH Vol. XI, ISSUE 2 Supplement, 2011, Romania The JOURNAL is nationally acknowledged by C.N.C.S.I.S., being included in the B+ category publications, 2008-2011. The journal is indexed in: Ebsco, SPORTDiscus, INDEX COPERNICUS JOURNAL MASTER LIST, DOAJ DIRECTORY OF OPEN ACCES JOURNALS, Caby, Gale Cengace Learning TYPOLOGY AND PROFILE OF SPINE MUSCLES. STRUCTURE OF MYOFIBRILS AND ROLE OF PROTEIN COMPONENTS – REVIEW OF CURRENT LITERATURE STRATON ALEXANDRU1, ENE-VOICULESCU CARMEN1, GIDU DIANA1, PETRESCU ANDREI1 Abstract. Muscular profile of spine muscles has a great importance in trunk stability. It seems that muscles which support the spine show a high content of red muscle fiber with a cross section area equal or higher than white muscle fibers. It is possible that lumbar extensor muscles to have different functional capacity between sexes. Most of the myofibril structural proteins except protein actin and protein myosin have a role in maintaining the structural integrity of muscle cell. Key words: muscle, fibres, myofibrils, proteins, spine. thoracic muscle structure lying superficial and deep is Introduction composed of 74% type I fibers, lumbar muscle Proper understanding of muscle fibers profile of structure located superficially is composed of 57% muscles supporting the spine and the role of muscle type I fibers and lumbar muscle structure located deep cell structural proteins leads to better achievements in is composed of 63% type I fibers. Type I muscle fiber performance training and rehabilitation. diameter is significantly larger than that of type II fibers. Another study, conducted on 42 patients Muscle fibers typology divided into two groups - 21 patients with lumbar Skeletal muscle contains two major types of back pain and 21 patients without lumbar back pain muscle fibers: slow twitch red or type I fibers) and almost identical groups as gender, age and body mass fast twitch white or type II fibers). Slow fibers reach index) showed that back muscles of patients with peak tension in about 110ms milliseconds) from the lumbar back pain, has a higher glycolitic profile rich moment of stimulation, and rapid fibers reach peak in white fibers) A. F. Mannion et al., 1997b). tension in about 50ms from the moment of Mannion A. F. et al., 1997a), in a study of 17 male stimulation. So, fast twitch fibers have a rapid subjects and 14 female subjects, using the method of response time to stimulation, more than twice reported muscle biopsies performed in the corresponding spinal to slow twitch fibers. extensor of ten thoracic vertebrae and three lumbar Until now, we have identified only one type of vertebrae, showed that the ratio of cross-sectional area slow twitch fibers and four types of fast twitch fibers: and the smallest diameter of the corresponding muscle IIa oxidative-glycolitic, IIx oxidative glycolitic which fiber is higher in the thoracic region, compared to the has some physiological and biochemical differences, lumbar region. Also, no significant differences were such as time of contraction, motoneuron size, fatigue found between the two regions on the percentage of resistance or oxidative capacity, maximum time of type I fibers, cross-sectional relative area of type I use, power output, mitochondrial density, etc., than IIa fibers and the ratio of cross sectional areas of type I fibers), IIb predominantly glycolitic and IIc A. Nicu fibers and, respectively, type II fibers. Male subjects şi L. Baroga, 1993) which contain transformation have a muscle fiber cross-sectional area bigger than myosin, characterized by the shift from the fast twitch female subjects for all types of muscle fibers and in fibers to slow twitch fibers G. Dumitru, 1994). The both regions - thoracic and lumbar - of the spine. Also, difference between type IIa fibers and type IIb male subjects have a similar average of cross-sectional predominantly glycolitic is characterized mainly by area for all types of muscle fibers, compared to female fatigue and oxidative capacity and frequency of subjects, who have an average cross-sectional area recruitment type IIa fibers, it seems that are increased in type I muscle fibers than type IIa fibers frequently recruited, than type IIb fibers); slow fibers and IIb fibers, the latter showing no significant are mostly recruited and type IIc fibers are poorly differences in average cross-sectional area. Therefore, recruited. fiber characteristics of spine extensor muscles differ On average, the vast majority of muscles are from those of skeletal muscles by, the relative composed of 50% type I fibres, 25% type IIa fibers, predominance in size of type I fibers slow twitch 22-24% type IIb fibers, and 1-3% type IIc fibers. fibers or red fibers), reflecting the complex role of However the exact percentage of these types of those muscles in maintaining posture Mannion A. F. muscle fibers varies considerably in different subjects et al., 1997a). and different muscles J. H. Wilmore and D. L. Also at the level of the spine extensor muscles, in a Costill, 1994). study of 16 subjects 9 male and 7 female, aged between 20 and 30 years) using the muscle biopsies Muscular profile at the level of thoraco-lumbar method performed in the lumbar region of the human spine erector spinae on multifidus and the longissimus Sirca A. and Kostevc V., 1985) showed that muscles, showed no significant differences between 1 Faculty of Physical Education and Sport, Ovidius University of Constanta, ROMANIA Email: [email protected] 627 Received 23.04.2011 / Accepted 19.06.2011 Ovidius University Annals, Series Physical Education and Sport / SCIENCE, MOVEMENT AND HEALTH Vol. XI, ISSUE 2 Supplement, 2011, Romania The JOURNAL is nationally acknowledged by C.N.C.S.I.S., being included in the B+ category publications, 2008-2011. The journal is indexed in: Ebsco, SPORTDiscus, INDEX COPERNICUS JOURNAL MASTER LIST, DOAJ DIRECTORY OF OPEN ACCES JOURNALS, Caby, Gale Cengace Learning the two muscles on the relative occurrence of type I form a helix structure F-actin), which at seven G- fibers 62% versus 57%), type IIa fibers 20% vs. actin monomers is twisted by about half arc circle. 22%), type IIb fibers 18% vs. 22%) and, on the Each chain of F-actin is a polymer composed of about absolute size of muscle fibers average between 58 200 G-actin molecules R. M. Enoka, 1994). Each G- and 66 microns). In female subjects, type I fibers actin monomer has an active site in which myosin occupied a larger relative area than male subjects 70- molecules can couple during muscle contraction. The 75% vs. 54-58%), even though the relative number of groove formed along the helix structure is a series of type I fibers was similar for both sexes. This can be fibrous elongated protein molecules called explained by a cross-sectional area of type II fibers tropomyosin. Each tropomyosin molecule spans on a smaller than the cross sectional area of type I fibers, in distance of seven G-actin monomers along F-actin women. These data suggest a different functional groove R. R. Seeley et al., 2004). At one of the ends capacity of the lumbar extensor muscles between of the tropomyosin molecule there is a protein sexes A. Thorstensson and H. Carlson, 1987). complex called troponin consisting of three adjacent Another study realised on 13 subjects 9 females subunits: troponin-C capable to reversibly bind and 4 males, aged between 24 and 55), using the calcium ions, troponin-T which attaches the this muscle biopsy from the abdominal muscles right complex troponin) on tropomyosin and troponin-I abdominal muscle, oblique external abdominal that has an inhibitory function inhibits four to seven muscle, oblique internal abdominal muscle and G-actin molecules to bind on the myosin, when transversal abdominal muscle) showed that there are tropomyosin is present). Troponin-C has four binding significant differences between subjects, in muscle sites, two for Ca2+ ions and two for Ca2+ ions or Mg2+ fiber type variation. Mean distribution of muscle ions R. M. Enoka, 1994). There are also, differences fibers was 55-58% type I fibers, 15-23% of type IIa in troponin-C protein, corresponding to fast fibers fibers, 21-28% of type IIb fibers and 0-1% type IIc compared to slow fibers S. V. Perry, 1985). fiber. Muscle fibers diameter was similar for most Troponin-tropomyosin complex regulates skeletal muscle groups studied average 50-54 microns), muscle contraction, through the influence of actin except transversal abdominal muscles which had a activity R. M. Enoka, 1994). smaller diameter for the type II fibers average 45 Fundamental unit of thick filaments is myosin, a microns). Also, muscle fiber composition, complex molecule with several distinct regions. Most histochemically studied at different abdominal of the length of this molecule forms a region often muscles, appear to exert similar functional capacity T. called the "tail" composed of light meromyosin Häqqmark and A. Thorstensson, 1979). LMM). The rest of the molecule, heavy meromyosin HMM), is composed of a protein chain that ends with Structure of myofibrils and role of protein a section called globular head. Globular portion, components called the S1 region subfragment 1) is responsible for Muscle-tendon structure is a complex biological chemical and enzymatic activity, which produces organ capable of generating considerable force in muscle contraction. It also contains the actin binding order to stabilize and/or move the body segments and site, which can interact with the thin filament, and the in energy absorption, which acts on the human body. place of ATP binding site, which is involved in energy This muscle-tendon structure is controlled by neural supply to achieve muscle contraction process. The impulses, generating power by converting chemical chain protein, called S2 region subfragment 2) serves energy into mechanical energy.
Recommended publications
  • Structural Biology of the Dystrophin-Deficient Muscle Fiber

    Structural Biology of the Dystrophin-Deficient Muscle Fiber

    Dystrophin-deficient muscle fiber REVIEW ISSN- 0102-9010145 STRUCTURAL BIOLOGY OF THE DYSTROPHIN-DEFICIENT MUSCLE FIBER Maria Julia Marques Department of Anatomy, Institute of Biology, State University of Campinas (UNICAMP), Campinas, SP, Brazil. ABSTRACT The discovery of dystrophin and its gene has led to major advances in our understanding of the molecular basis of Duchenne, Becker and other muscular dystrophies related to the dystrophin-associated protein complex. The concept that dystrophin has a mechanical function in stabilizing the muscle fiber membrane has expanded in the last five years. The dystrophin-glycoprotein complex is now considered a multifunctional complex that contains molecules involved in signal transduction cascades important for cell survival. The roles of dystrophin and the dystrophin- glycoprotein complex in positioning and anchoring receptors and ion channels is also important, and much of what is known about these functions is based on studies of the neuromuscular synapse. In this review, we discuss the components and the cellular signaling molecules associated with the dystrophin-glycoprotein complex. We then focus on the molecular organization of the neuromuscular junction and its structural organization in the dystrophin-deficient muscle fibers of mdx mice, a well-established experimental model of Duchenne muscular dystrophy. Key words: Confocal microscopy, Duchenne muscular dystrophy, mdx, neuromuscular junction INTRODUCTION that can improve the quality of life of the patients, Duchenne muscular dystrophy (DMD) is an X- death usually occurs in the early twenties, as a result linked recessive, progressive muscle-wasting disease of cardiac and/or respiratory failures [24]. that affects primarily skeletal and cardiac muscle. Several other muscular dystrophies have been DMD was first reported in 1868 by Dr.
  • Appropriate Roles of Cardiac Troponins in Evaluating Patients with Chest Pain

    Appropriate Roles of Cardiac Troponins in Evaluating Patients with Chest Pain

    J Am Board Fam Pract: first published as 10.3122/jabfm.12.3.214 on 1 May 1999. Downloaded from MEDICAL PRACTICE Appropriate Roles of Cardiac Troponins in Evaluating Patients With Chest Pain Matthew S. Rice, MD, CPT, Me, USA, and David C. MacDonald, DO, Me, USA Background: Diagnosis of acute myocardial infarction relies upon the clinical history, interpretation of the electrocardiogram, and measurement of serum levels of cardiac enzymes. Newer biochemical markers of myocardial injury, such as cardiac troponin I and cardiac troponin T, are now being used instead of or along with the standard markers, the MB isoenzyme of creatine kinase (CK-MB) and lactate dehydrogenase. Methods: We performed a MEDLINE literature search (1987 to 1997) using the key words "troponin I," "troponin T," and "acute myocardial infarction." We reviewed selected articles related to the diagnostic and prognostic usefulness of these cardiac markers in evaluating patients with suspected myocardial infarction. Results: We found that (1) troponin I is a better cardiac marker than CK-MB for myocardial infarction because it is equally sensitive yet more specific for myocardial injury; (2) troponin T is a relatively poorer cardiac marker than CK-MB because it is less sensitive and less specific for myocardial injury; and (3) both troponin I and troponin T may be used as independent prognosticators of future cardiac events. Conclusions: Troponin I is a sensitive and specific marker for myocardial injury and can be used to predict the likelihood of future cardiac events. It is not much more expensive to measure than CK-MB. Over­ all, troponin I is a better cardiac marker than CK-MB and should become the preferred cardiac enzyme when evaluating patients with suspected myocardial infarction.
  • Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular

    Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular

    JACC: BASIC TO TRANSLATIONAL SCIENCE VOL.4,NO.7,2019 ª 2019 THE AUTHORS. PUBLISHED BY ELSEVIER ON BEHALF OF THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION. THIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY-NC-ND LICENSE (http://creativecommons.org/licenses/by-nc-nd/4.0/). PRECLINICAL RESEARCH Gene Therapy Rescues Cardiac DysfunctioninDuchenneMuscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate a b c d,e Stephen C. Kolwicz, JR,PHD, John K. Hall, PHD, Farid Moussavi-Harami, MD, Xiolan Chen, PHD, d,e b,d,e e,f,g, b,e,g, Stephen D. Hauschka, PHD, Jeffrey S. Chamberlain, PHD, Michael Regnier, PHD, * Guy L. Odom, PHD * VISUAL ABSTRACT Kolwicz, S.C. Jr. et al. J Am Coll Cardiol Basic Trans Science. 2019;4(7):778–91. HIGHLIGHTS rAAV vectors increase cardiac-specific expression of RNR and elevate cardiomyocyte 2-dATP levels. Elevated myocardial RNR and subsequent increase in 2-dATP rescues the performance of failing myocardium, an effect that persists long term. ISSN 2452-302X https://doi.org/10.1016/j.jacbts.2019.06.006 JACC: BASIC TO TRANSLATIONAL SCIENCE VOL. 4, NO. 7, 2019 Kolwicz, Jr., et al. 779 NOVEMBER 2019:778– 91 Nucleotide-Based Cardiac Gene Therapy Restores Function in dmd Mice We show the ability to increase both cardiac baseline function and high workload contractile performance in ABBREVIATIONS aged (22- to 24-month old) mdx4cv mice, by high-level muscle-specific expression of either microdystrophin AND ACRONYMS or RNR. mDys = microdystrophin Five months post-treatment, mice systemically injected with rAAV6 vector carrying a striated muscle-specific CK8 regulatory cassette driving expression of microdystrophin in both skeletal and cardiac muscle, exhibited the = miniaturized murine creatine kinase regulatory greatest effect on systolic function.
  • Hypertrophic Cardiomyopathy- Associated Mutations in Genes That Encode Calcium-Handling Proteins

    Hypertrophic Cardiomyopathy- Associated Mutations in Genes That Encode Calcium-Handling Proteins

    Current Molecular Medicine 2012, 12, 507-518 507 Beyond the Cardiac Myofilament: Hypertrophic Cardiomyopathy- Associated Mutations in Genes that Encode Calcium-Handling Proteins A.P. Landstrom and M.J. Ackerman* Departments of Medicine, Pediatrics, and Molecular Pharmacology & Experimental Therapeutics, Divisions of Cardiovascular Diseases and Pediatric Cardiology, and the Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota, USA Abstract: Traditionally regarded as a genetic disease of the cardiac sarcomere, hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease and a significant cause of sudden cardiac death. While the most common etiologies of this phenotypically diverse disease lie in a handful of genes encoding critical contractile myofilament proteins, approximately 50% of patients diagnosed with HCM worldwide do not host sarcomeric gene mutations. Recently, mutations in genes encoding calcium-sensitive and calcium- handling proteins have been implicated in the pathogenesis of HCM. Among these are mutations in TNNC1- encoded cardiac troponin C, PLN-encoded phospholamban, and JPH2-encoded junctophilin 2 which have each been associated with HCM in multiple studies. In addition, mutations in RYR2-encoded ryanodine receptor 2, CASQ2-encoded calsequestrin 2, CALR3-encoded calreticulin 3, and SRI-encoded sorcin have been associated with HCM, although more studies are required to validate initial findings. While a relatively uncommon cause of HCM, mutations in genes that encode calcium-handling proteins represent an emerging genetic subset of HCM. Furthermore, these naturally occurring disease-associated mutations have provided useful molecular tools for uncovering novel mechanisms of disease pathogenesis, increasing our understanding of basic cardiac physiology, and dissecting important structure-function relationships within these proteins.
  • Post-Translational Modifications Regulate Cytoskeletal Proteins in Heart Disease Related Publications JULY Research Tools 2016

    Post-Translational Modifications Regulate Cytoskeletal Proteins in Heart Disease Related Publications JULY Research Tools 2016

    CYTOSKELETON NEWS NEWS FROM CYTOSKELETON INC. Post-translational Modifications Regulate Cytoskeletal Proteins in Heart Disease Related Publications JULY Research Tools 2016 v Meetings PTMs Regulate Cytoskeletal Proteins in Heart Disease GRC - Muscle and Molecular Cardiovascular disease accounts for roughly one in every three mechanotransduction7. Use of SiR-tubulin technology to perform Motors News deaths in the USA with heart disease accounting for the majority high-speed, sub-diffraction imaging revealed that detyrosination July 17-22. West Dover, VT of these cases1. The pathology of heart disease often involves of α-tubulin was critical for anchoring MTs to sarcomeres in order GRC - Plant and Microbial the death or dysfunction of cardiomyocytes, specialized heart to regulate MT buckling during contraction8 (Fig. 1). Furthermore, Cytoskeleton cells that produce the contractile, beating function of the heart. detyrosination was significantly increased in patients with August 14-19. Andover, NH Many different proteins and cell machinery, such as ion channels clinically diagnosed hypertrophic and dilated cardiomyopathies, and pumps, cytoskeletal proteins, and receptors play a significant while acetylation and glycosylation of α-tubulin did not play a The Triangle Cytoskeleton 8 Meeting role in regulating the contractile ability of cardiomyocytes. significant role in MT buckling . It will be interesting to determine September. NC, USA Interestingly, many of these proteins are regulated through post- which PTMs regulate alternative functions of MTs in heart disease. translational modifications (PTMs), in part because PTMs allow Society for Neuroscience for rapid, but subtle changes to a protein as part of an overall November, 12-16 cellular response2. For example, SUMOylation of the critical Rest 2+ A Booth # 2417 sarco/endoplasmic reticulum Ca -ATPase 2a (SERCA2a) pump Publications San Diego, CA was diminished in failing human heart samples3.
  • Troponin C Fast Skeletal (E-7): Sc-48347

    Troponin C Fast Skeletal (E-7): Sc-48347

    SANTA CRUZ BIOTECHNOLOGY, INC. Troponin C fast skeletal (E-7): sc-48347 BACKGROUND APPLICATIONS Actin is a highly conserved protein that is expressed in all eukaryotic cells. Troponin C fast skeletal (E-7) is recommended for detection of fast skeletal Actin filaments can form both stable and labile structures and are crucial isoform of Troponin C of mouse, rat and human origin by Western Blotting components of microvilli and the contractile apparatus of muscle cells. Myosin (starting dilution 1:100, dilution range 1:100-1:10000), immunoprecipitation is a hexamer of two heavy chains (MHC) and four light chains (MLC) that inter- [1-2 µg per 100-500 µg of total protein (1 ml of cell lysate)], immunofluo- acts with Actin to generate the force for diverse cellular movements, including rescence (starting dilution 1:50, dilution range 1:50-1:500), immunohisto- cytokinesis, phagocytosis and muscle contraction. Troponin facilitates the chemistry (including paraffin-embedded sections) (starting dilution 1:50, interaction between Actin and myosin by binding to calcium. Troponin is dilution range 1:50-1:500) and solid phase ELISA (starting dilution 1:30, made up of at least two subunits, which are divergent in cardiac muscle, dilution range 1:30-1:3000). fast skeletal muscle and slow skeletal muscle. Structures of skeletal muscle Suitable for use as control antibody for Troponin C fast skeletal Troponin are composed of Troponin C (the sensor), Troponin I (the regulator) siRNA (h): sc-36736, Troponin C fast skeletal siRNA (m): sc-36737, and Troponin T (the link to the muscle thin filament). Troponin C is dumbbell- Troponin C fast skeletal shRNA Plasmid (h): sc-36736-SH, shaped and has a hydrophobic pocket that increases the contractile force of Troponin C fast skeletal shRNA Plasmid (m): sc-36737-SH, muscle fibers.
  • Alterations in Keratin Levels and Modifications in Colorectal Adenomagenesis Ria Rosser

    Alterations in Keratin Levels and Modifications in Colorectal Adenomagenesis Ria Rosser

    Alterations in Keratin Levels and Modifications in Colorectal Adenomagenesis Ria Rosser January 2016 Supervisors: BM Corfe and KS Chapple Department of Oncology Thesis submitted to the University of Sheffield for the degree of Doctor of Medicine 2 Alterations in Keratin Levels and Modifications in Colorectal Adenomagenesis Table of Contents Abstract ................................................................................................................................. 7 Acknowledgments ............................................................................................................. 9 List of Figures ................................................................................................................... 11 List of Tables .................................................................................................................... 13 Abbreviations .................................................................................................................. 15 Chapter 1 Literature review ....................................................................................... 19 1.1 The History of Adenomatous polyps ................................................................. 19 1.1.1 Origins of the Adenoma ............................................................................................... 20 1.1.2 Adenoma-Carcinogenesis model ......................................................................................... 24 1.2 Field effects – Theory and Definitions .............................................................
  • Syncoilin Modulates Peripherin Filament Networks and Is Necessary for Large-Calibre Motor Neurons

    Syncoilin Modulates Peripherin Filament Networks and Is Necessary for Large-Calibre Motor Neurons

    Research Article 2543 Syncoilin modulates peripherin filament networks and is necessary for large-calibre motor neurons W. Thomas Clarke1,*, Ben Edwards1,*, Karl J. A. McCullagh1,‡, Matthew W. Kemp1,§, Catherine Moorwood1,¶, Diane L. Sherman2, Matthew Burgess1,** and Kay E. Davies1,‡‡ 1MRC Functional Genomics Unit, Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, Oxford, OX1 3PT, UK 2Centre for Neuroscience Research, The University of Edinburgh, Summerhall, Edinburgh, EH9 1QH, UK *These authors contributed equally to this work ‡Present address: Regenerative Medicine Institute, National Centre for Biomedical Engineering Science, National University of Ireland, Galway, Ireland §Present address: School of Women’s and Infants’ Health, Faculty of Medicine, Dentistry and Health Sciences, The University of Western Australia, Western Australia, WA 6009 ¶Present address: Department of Physiology and Pennsylvania Muscle Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA **Present address: Botnar Research Centre, Institute of Musculoskeletal Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford OX3 7LD, UK ‡‡Author for correspondence ([email protected]) Accepted 20 April 2010 Journal of Cell Science 123, 2543-2552 © 2010. Published by The Company of Biologists Ltd doi:10.1242/jcs.059113 Summary Syncoilin is an atypical type III intermediate filament (IF) protein, which is expressed in muscle and is associated with the dystrophin- associated protein complex. Here, we show that syncoilin is expressed in both the central and peripheral nervous systems. Isoform Sync1 is dominant in the brain, but isoform Sync2 is dominant in the spinal cord and sciatic nerve. Peripherin is a type III IF protein that has been shown to colocalise and interact with syncoilin.
  • Prolonged Controlled Mechanical Ventilation in Humans Triggers

    Prolonged Controlled Mechanical Ventilation in Humans Triggers

    Thorax Online First, published on March 31, 2016 as 10.1136/thoraxjnl-2015-207559 Respiratory research ORIGINAL ARTICLE Thorax: first published as 10.1136/thoraxjnl-2015-207559 on 31 March 2016. Downloaded from Prolonged controlled mechanical ventilation in humans triggers myofibrillar contractile dysfunction and myofilament protein loss in the diaphragm Sabah N A Hussain,1,2,3 Anabelle S Cornachione,4 Céline Guichon,1 Auday Al Khunaizi,1 Felipe de Souza Leite,5 Basil J Petrof,3 Mahroo Mofarrahi,1 Nikolay Moroz,1 Benoit de Varennes,6 Peter Goldberg,1,3 Dilson E Rassier7 ▸ Additional material is ABSTRACT published online only. To view Background Prolonged controlled mechanical Key messages please visit the journal online (http://dx.doi.org/10.1136/ ventilation (CMV) in humans and experimental animals thoraxjnl-2015-207559). results in diaphragm fibre atrophy and injury. In animals, fi fi prolonged CMV also triggers signi cant declines in What is the key question? For numbered af liations see fi end of article. diaphragm myo bril contractility. In humans, the impact ▸ Does prolonged controlled mechanical of prolonged CMV on myofibril contractility remains ventilation (CMV) in humans alter the unknown. The objective of this study was to evaluate contractile performance and myofilament Correspondence to the effects of prolonged CMV on active and passive protein expression in diaphragm myofibrils? Professor Dilson Rassier, human diaphragm myofibrillar force generation and Department of Kinesiology, myofilament protein levels. What is the bottom line? McGill University, 475 Pine Ave ▸ Prolonged CMV in humans significantly West, Montréal, Québec, Methods and results Diaphragm biopsies were Canada H2W 1S4; dilson.
  • The Toxic Effect of R350P Mutant Desmin in Striated Muscle of Man and Mouse

    The Toxic Effect of R350P Mutant Desmin in Striated Muscle of Man and Mouse

    Acta Neuropathol (2015) 129:297–315 DOI 10.1007/s00401-014-1363-2 ORIGINAL PAPER The toxic effect of R350P mutant desmin in striated muscle of man and mouse Christoph S. Clemen · Florian Stöckigt · Karl-Heinz Strucksberg · Frederic Chevessier · Lilli Winter · Johanna Schütz · Ralf Bauer · José-Manuel Thorweihe · Daniela Wenzel · Ursula Schlötzer-Schrehardt · Volker Rasche · Pavle Krsmanovic · Hugo A. Katus · Wolfgang Rottbauer · Steffen Just · Oliver J. Müller · Oliver Friedrich · Rainer Meyer · Harald Herrmann · Jan Wilko Schrickel · Rolf Schröder Received: 1 September 2014 / Revised: 14 October 2014 / Accepted: 30 October 2014 / Published online: 14 November 2014 © The Author(s) 2014. This article is published with open access at Springerlink.com Abstract Mutations of the human desmin gene on chro- Furthermore, we demonstrate that the missense-mutant mosome 2q35 cause autosomal dominant, autosomal reces- desmin inflicts changes of the subcellular localization and sive and sporadic forms of protein aggregation myopathies turnover of desmin itself and of direct desmin-binding part- and cardiomyopathies. We generated R349P desmin knock- ners. Our findings unveil a novel principle of pathogenesis, in mice, which harbor the ortholog of the most frequently in which not the presence of protein aggregates, but disrup- occurring human desmin missense mutation R350P. These tion of the extrasarcomeric intermediate filament network mice develop age-dependent desmin-positive protein aggre- leads to increased mechanical vulnerability of muscle fib- gation pathology, skeletal muscle weakness, dilated cardio- ers. These structural defects elicited at the myofiber level myopathy, as well as cardiac arrhythmias and conduction finally impact the entire organ and subsequently cause defects. For the first time, we report the expression level myopathy and cardiomyopathy.
  • Genetic Restrictive Cardiomyopathy: Causes and Consequences—An Integrative Approach

    Genetic Restrictive Cardiomyopathy: Causes and Consequences—An Integrative Approach

    International Journal of Molecular Sciences Review Genetic Restrictive Cardiomyopathy: Causes and Consequences—An Integrative Approach Diana Cimiotti 1,* , Heidi Budde 2, Roua Hassoun 2 and Kornelia Jaquet 2,* 1 Department of Clinical Pharmacology, Ruhr-University Bochum, 44801 Bochum, Germany 2 Experimental and Molecular Cardiology, St. Josef Hospital and BG Bergmannsheil, Clinics of the Ruhr-University Bochum, 44791 Bochum, Germany; [email protected] (H.B.); [email protected] (R.H.) * Correspondence: [email protected] (D.C.); [email protected] (K.J.); Tel.: +49-234-32-27639 (D.C.) Abstract: The sarcomere as the smallest contractile unit is prone to alterations in its functional, structural and associated proteins. Sarcomeric dysfunction leads to heart failure or cardiomyopathies like hypertrophic (HCM) or restrictive cardiomyopathy (RCM) etc. Genetic based RCM, a very rare but severe disease with a high mortality rate, might be induced by mutations in genes of non- sarcomeric, sarcomeric and sarcomere associated proteins. In this review, we discuss the functional effects in correlation to the phenotype and present an integrated model for the development of genetic RCM. Keywords: cardiomyopathy; restrictive cardiomyopathy; pediatric; sarcomere; contractile dysfunc- tion; calcium; aggregation; gene expression 1. The Sarcomere The sarcomere as the substructure of myofibrils is the contractile unit of striated muscles i.e. skeletal and cardiac muscle (Figure1). It forms a symmetric unit with the Citation: Cimiotti, D.; Budde, H.; M-disc in the center and is bordered by the Z-discs. M-disc and Z-disc provide the anchors Hassoun, R.; Jaquet, K. Genetic for thin, thick and elastic filaments. The elastic filament is composed of the giant protein Restrictive Cardiomyopathy: Causes and Consequences—An Integrative titin spanning half the sarcomere.
  • Cytoskeletal Proteins in Neurological Disorders

    Cytoskeletal Proteins in Neurological Disorders

    cells Review Much More Than a Scaffold: Cytoskeletal Proteins in Neurological Disorders Diana C. Muñoz-Lasso 1 , Carlos Romá-Mateo 2,3,4, Federico V. Pallardó 2,3,4 and Pilar Gonzalez-Cabo 2,3,4,* 1 Department of Oncogenomics, Academic Medical Center, 1105 AZ Amsterdam, The Netherlands; [email protected] 2 Department of Physiology, Faculty of Medicine and Dentistry. University of Valencia-INCLIVA, 46010 Valencia, Spain; [email protected] (C.R.-M.); [email protected] (F.V.P.) 3 CIBER de Enfermedades Raras (CIBERER), 46010 Valencia, Spain 4 Associated Unit for Rare Diseases INCLIVA-CIPF, 46010 Valencia, Spain * Correspondence: [email protected]; Tel.: +34-963-395-036 Received: 10 December 2019; Accepted: 29 January 2020; Published: 4 February 2020 Abstract: Recent observations related to the structure of the cytoskeleton in neurons and novel cytoskeletal abnormalities involved in the pathophysiology of some neurological diseases are changing our view on the function of the cytoskeletal proteins in the nervous system. These efforts allow a better understanding of the molecular mechanisms underlying neurological diseases and allow us to see beyond our current knowledge for the development of new treatments. The neuronal cytoskeleton can be described as an organelle formed by the three-dimensional lattice of the three main families of filaments: actin filaments, microtubules, and neurofilaments. This organelle organizes well-defined structures within neurons (cell bodies and axons), which allow their proper development and function through life. Here, we will provide an overview of both the basic and novel concepts related to those cytoskeletal proteins, which are emerging as potential targets in the study of the pathophysiological mechanisms underlying neurological disorders.